Current Epidemiology and Clinical Features of <i>Cryptococcus</i> Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Hugh McGann, Anthony Longhitano et al.|Clinical Infectious Diseases|2023Cited by 56
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M. Mullane, P Chilingirov, Vicki A. Morrison et al.|The Lancet Infectious Diseases|2019Cited by 36
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised PatientsRosemary A. Barnes, Johan Maertens, Stephanie Earnshaw et al.|Clinical Therapeutics|2015Cited by 27